CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society

About CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society

For more than 75 years, the American Cancer Society (ACS) has published some of the most respected peer-reviewed journals in oncology. CancerSpeak, the official podcast of the ACS Journals, brings this legacy to life through conversations with experts in clinical oncology and related disciplines, connecting listeners with the research and perspectives featured across its titles. Originally launched in 2023 to highlight research from Cancer, the podcast is expanding to feature work across the full ACS journals portfolio, including CA: A Cancer Journal for Clinicians, Cancer Cytopathology, and Pediatric, Adolescent & Young Adult Cancer. Each episode examines timely topics with leading experts in their fields, including recent studies, new clinical guidance, and major highlights from annual meetings. When possible, episodes incorporate the patient experience, highlighting the real-world impact of the work we publish.

Publisher

ACS Journal Cancer

Category

health & fitness · science

Language

en

Explicit

No

First episode

16 Aug 2023

Latest episode

22 Sept 2026

Latest episodes

26 episodes in the feed.

1. 

   22 Sept 2026

   Annual Report to the Nation: Cancer Trends and Progress Against Lung Cancer

   What do the latest data tell us about cancer in the United States, and what’s behind the substantial progress against lung cancer over the past two decades? In this episode of CancerSpeak, Jane Henley, MSPH, of the Centers for Disease Control and Prevention (CDC), is joined by Ahmedin Jemal, DVM, PhD, of the American Cancer Society (ACS); Serban Negoita, MD, DrPH, of the National Cancer Institute (NCI); and Recinda L. Sherman, MPH, PhD, ODS-C, of the North American Association of Central Cancer Registries (NAACCR) to discuss findings from the latest Annual Report to the Nation on the Status of Cancer. The group explores trends in cancer incidence and mortality, 21st century progress against lung cancer, changing breast and prostate cancer incidence, and findings among children, adolescents, and young adults. Read “Annual Report to the Nation on the Status of Cancer, Featuring 21st Century Progress Against Lung Cancer,” now available in Cancer: https://bit.ly/ARNReport2026 Follow Cancer on social media: x.com/JournalCancerinstagram.com/acsjournalslinkedin.com/company/acs-journals Speakers in this conversation may have used shortened or informal terms rather than the precise terminology used in the published report. Please refer to the published article for exact definitions, categories, and classifications. The findings and conclusions presented do not necessarily represent the official positions of the CDC; NCI, part of the National Institutes of Health; ACS; or NAACCR. Original music by J. Gilman.

2. 

   9 Sept 2026

   Advancing Pediatric and AYA Oncology: Perspectives from the Editors

   Where is pediatric and adolescent and young adult (AYA) oncology headed—and what research is needed to move the field forward? In this episode of CancerSpeak, Dr. Nirali Shah, Editor-in-Chief of Pediatric, Adolescent & Young Adult Cancer, sits down with Associate Editors Dr. Julia Glade Bender and Dr. Jonathan Metts to share their perspectives on the questions, challenges, and opportunities shaping pediatric and AYA cancer research today. Together, they discuss areas of unmet need, research they believe merits greater attention, and the kinds of studies they're eager to see submitted to the new journal. Drs. Glade Bender and Metts also reflect on the unique expertise they contribute to the editorial team and their excitement about helping shape the vision, direction, and foundation of Pediatric, Adolescent & Young Adult Cancer in its early years. To explore Pediatric, Adolescent & Young Adult Cancer, sign up for alerts, and submit a manuscript, visit the journal homepage: https://acsjournals.onlinelibrary.wiley.com/journal/30683513 Follow Pediatric, Adolescent & Young Adult Cancer on social media:x.com/PedAYAJournalinstagram.com/acsjournalslinkedin.com/company/acs-journals Original music by J.Gilman.

3. 

   11 Aug 2026

   Optimizing Asparaginase and Blinatumomab in Frontline Acute Lymphoblastic Leukemia

   What are the latest recommendations for frontline acute lymphoblastic leukemia (ALL) treatment? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is joined by Dr. Daniel DeAngelo and Dr. David McCall to discuss a new international expert consensus statement on optimizing the safety and efficacy of asparaginase and blinatumomab in frontline ALL treatment. They walk through the key recommendations from the consensus statement, exploring how these therapies fit into modern treatment approaches and what clinicians should consider when applying these strategies across different healthcare settings. Read the full consensus statement in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70559 Follow Cancer on social media:x.com/JournalCancerinstagram.com/acsjournalslinkedin.com/company/acs-journals Original music by J. Gilman.

Who has been a guest on CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society

Names identified in recent episode analyses. Showing up to five guests.

• Samuel Butensky
• Elizabeth Godfrey
• Dr Elizabeth Godfrey
• Dr Michael White
• Dr Mustafa Raoof

Podcast Authority Score: 3 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

6

Social presence

0

YouTube

0

Engagement

0

Contact CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.